T categories for colorectal cancer of the AJCC staging system.
Observation of the mucosal crypt patterns using chromoendoscopy with magniﬁcation has been reported to be the most reliable method for determining whether a colorectal cancer (CRC) is early or advanced tumour. Moreover, brand-new endoscopic system have the capability to enhance visibility by the capillary pattern, which may prove to be reliable for detection of deep submucosal invasive CRC.
Early CRC is deﬁned as a tumour whose invasion is limited to the mucosa or submucosa. The endoscopic mucosal resection and endoscopic mucosal dissection (EMR/ESD) have become useful for early CRC. However, EMR/ESD is applicable only to intramucosal carcinoma, and additional surgery is required if the resected lesion reveals submucosal invasion by pathological diagnosis. Therefore, endoscopist and surgical pathologist considered that it would be very useful to predict the depth of invasion of submucosal invasive CRC before EMR/ESD. On the other hand, desmoplastic reaction (DR) which is characterized by the inﬁltration of eosinophilic myoﬁbroblasts in the stroma of invasive carcinoma is suggested to be a prognostic marker in CRC patients.
Here we describe that detection of DR in pre-treatment biopsy specimens is useful for predicting the depth of submucosal invasion and evaluation of submucosal depth with head invasion or stalk invasion in post EMR/ESD specimen is useful for predicting the lymph node metastasis and discuss relevant issues in arriving at the correct differential diagnosis based on histological findings for gastrointestinal endoscopist and surgical pathologist.
2. Correlations between lymph node metastasis and early colorectal carcinoma
The endoscopic mucosal resection and endoscopic submucosal dissection (EMR/ESD) have become useful for early CRC which is deﬁned as a T1 stage tumour whose invasion is limited to the mucosa or submucosa according to the T categories for colorectal cancer of the American Joint Committee on Cancer (AJCC) staging system (Table 1).
|Tx: No description of the tumor's extent is possible because of incomplete information.|
|Tis: The cancer is in the earliest stage (in situ). It involves only the mucosa. It has not grown beyond the muscularis mucosa (inner muscle layer).|
|T1: The cancer has grown through the muscularis mucosa and extends into the submucosa.|
|T2: The cancer has grown through the submucosa and extends into the muscularis propria (thick outer muscle layer).|
|T3: The cancer has grown through the muscularis propria and into the outermost layers of the colon or rectum but not through them. It has not reached any nearby organs or tissues.|
|T4a: The cancer has grown through the serosa (also known as the visceral peritoneum), the outermost lining of the intestines.|
|T4b:The cancer has grown through the wall of the colon or rectum and is attached to or invades into nearby tissues or organs.|
The endoscopic mucosal dissection (EMR: endoscopic mucosal resection and ESD: endoscopic submucosal dissection) of intramucosal carcinoma is accepted as curative, as there is almost negative of lymph node metastasis. [1-4]. However, the reported prevalence rates of lymph node metastasis range from 6 to 12% of all patients with submucosal invasive colorectal carcinoma (SICC) [3-6]. Therefore, the endoscopic mucosal dissected cases of SICC with lymph node metastasis, and after EMR/ESD, surgical resection accompanied with lymph node dissection is necessary.
It has been known that we should be considered be additional resection is required due to the risk of lymph node metastasis following ﬁndings (1) massive submucosal invasion: (2) lymphatic/vessel invasion; or (3) poorly differentiated component in resected EMR/ESD specimens [7, 8]. There has been no standard method of measurement of submucosal invasion depth. Therefore, Japanese Society for Cancer of the Colon and Rectum has recently demonstrated definite for method of measurement of submucosal invasion depth.
3. Ip type (pedunculated lesion) and non-Ip type (nonpedunculated lesion) of early colorectal carcinoma
Macroscopic type (endoscopic finding) was assessed according to the macroscopic classiﬁcation of early stomach carcinoma, with minor modiﬁcations. In shortly, SICCs were divided into two lesions: pedunculated (Ip type) (Figure. 1, Figure. 2(a)) and nonpedunculated (Non-Ip type) (Figure. 1b, Figure. 2(b)). Nonpedunculated lesion were subclassiﬁed as semipedunculated lesion (Isp type) and sessile lesion (Is type). Respectively. Ip type (pedunculated lesion) has typically head with stalk (Figure. 1, Figure 2).
The method used for measurement of submucosal invasion depth (Figure. 3)
Firstly, EMR/ESD resected specimens are divided into pedunculated(Ip type) and nonpedunculated(Non-Ip type). For pedunculated SICC, level 2 according to Haggitt’s classiﬁcation  was used as the baseline (so-called Haggitt’s line), and submucosal invasion depth was measured as the vertical distance from this line to the deepest site of invasion. The baseline to distinguish between head invasion, (Figure. 4(a)) and stalk invasion, (Figure. 4(b)). In head invasion, submucosal invasion depth was regarded as 0 µm. When the deepest portion of invasion was located below the baseline, the case was deﬁned as a stalk invasion and the vertical distance from this line to the deepest portion of invasion was utilized as submucosal invasion depth.
On the other hand, nonpedunculated and when the muscularis mucosae could be identiﬁed in hematoxylin and eosin stain, the muscularis mucosae was used as baseline and the vertical distance from this line to the deepest site of invasion represented submucosal invasion depth, (Figure. 4(c))., however, when the muscularis mucosae could not be identiﬁed, the superﬁcial aspect of the SICC was used as baseline, (Figure. 4(d)).
4. Correlations between lymph node metastasis and depth of submucosal invasive colorectal carcinoma
The Japanese collaborative retrospectively study for 865 SICCs. This nationwide survey not only represents a ﬁrst for Japan, but reviewing the literature using PubMed revealed no similar surveys from anywhere in the world at that time  This study reported that pedunculated (Ip type) SICC, rate of lymph node metastasis was never in head invasion cases and stalk invasion cases with submucosal invasion depth < 3000 µm if lymphatic invasion was negative (Table 2).
And, For nonpedunculated (non-Ip type) SICC, rate of lymph node metastasis was also 0% if submucosal invasion depth was <1000 µm (Table 3). In multivariate analysis, SM depth <1000µm (P <0.006), sprouting (P <0.002), and lymphatic invasion (P<0.0001) represented signiﬁcant risk factors, with odds ratios of 5.404, 2.276, and 4.691, respectively. Several priviously reports suggested that prognosis in patients with early colorectal carcinoma based on Haggitt’s classiﬁcation, ﬁnding that level 4 which is carcinoma invading the submucosa of the bowel wall below the stalk of the polyp but above the muscularis propria, represented the most important factor for lymph node metastasis [9, 10]. Therefore, these results revealed that submucosal invasion could be an important of predicting lymph node metastasis potential.
|LNM (+)||Ly (+)||V (+)||Sp (+)||wel, mod||por|
|SM depth (µm)||(%)||(%)||(%)||(%)||(%)||(%)|
|X=0 (n=53)||3 (5.7)||15 (28.3)||9 (17.0)||15 (28.3)||51 (96.2)||2 (3.8)|
|0 <X<500 (n=10)||0 (0)||2 (20.0)||0 (0)||3 (33.3)||10 (100)||0 (0)|
|500≤X<1000 (n=7)||0 (0)||1 (14.3)||0 (0)||2 (28.6)||7 (100)||0 (0)|
|1000≤X<1500 (n=11)||1 (9.1)||2 (18.2)||3 (27.3)||7 (63.6)||11 (100)||0 (0)|
|1500≤X<2000 (n = 7)||1 (14.3)||4 (57.1)||0 (0)||5 (71.4)||7 (100)||0 (0)|
|2000 ≤X<2500 (n= 10)||1 (10.0)||4 (40.0)||3 (30.0)||1 (10.0)||9 (90.0)||1 (10.0)|
|2500≤X< 3000 (n= 4)||0 (0)||0 (0)||2 (50)||1 (25.0)||4 (100)||0 (0)|
|3000 ≤X<3500 (n= 9)||2 (22.2)||4 (44.4)||3 (33.3)||5 (55.6)||8 (88.9)||1 (11.1)|
|3500 ≤X (n= 30)||2 (6.7)||9 (30.0)||10 (33.3)||10 (33.3)||28 (93.3)||2 (6.7)|
|LNM (+)||Ly (+)||V (+)||Sp (+)||wel, mod||por||Identiﬁed||Not identiﬁed|
|SM depth (µm)||(%)||(%)||(%)||(%)||(%)||(%)||(%)||(%)|
|0 (0)||5 (7.7)||3 (4.6)||9 (13.8)||64 (98.5)||1 (1.5)||64 (98.5)||1 (1.5)|
|500≤X<1000 (n=58)||0 (0)||12 (20.7)||7 (12.1)||7 (12.1)||58 (100)||0 (0)||51 (87.9)||7 (12.1)|
|6 (11.5)||16 (30.8)||12 (23.1)||16 (30.8)||51 (98.1)||1 (1.9)||36 (69.2)||16 (30.8)|
(n = 82)
|10 (12.2)||27 (32.9)||16 (19.5)||37 (45.1)||82 (100)||0 (0)||48 (58.5)||34 (41.5)|
|13 (15.5)||28 (33.3)||21 (25.0)||42 (50.0)||78 (92.9)||6 (7.1)||31 (36.9)||53 (63.1)|
|2500≤X< 3000 (n= 71)||8 (11.3)||29 (40.8)||16 (22.5)||38 (53.5)||71 (100)||0 (0)||20 (28.2)||51 (71.8)|
|5 (6.9)||26 (36.1)||15 (20.8)||35 (48.6)||69 (95.8)||3 (4.2)||16 (22.2)||56 (77.8)|
|35 (14.6)||92 (38.3)||74 (30.8)||133 (55.4)||237 (98.8)||3 (1.2)||48 (20.0)||192 (80.0)|
Suprisingly, Japanese collaborative retrospectively nationwide survey shows both of Ip type (pedunculated lesion) and non-Ip type (nonpedunculated lesion) of early colorectal carcinoma with rate of lymph node metastasis was also 0% if submucosal invasion depth was <1000 µm (Table 4). It is easy to measure one southern micrometer using by small ruler under microscopy for surgical pathologist. When if submucosal invasion depth was 1000 µm ≤, surgical pathologist should be advice to gastrointestinal endoscopist. And recently Japanese large-scale multicenter retrospectively study for 384 (head invasion: 240, stalk invasion: 144) pedunculated (Ip type) SICCs demonstrated that incidence of lymph node metastasis was 3.5%. the incidence of lymph node metastasis was 0.0% inpatients with head invasion, ascompared with 6.2% in patients with stalk invasion (Tabel 4). Pedunculated type early invasive colorectal cancers pathologically diagnosed as head invasion can be only treated by endoscopic resection.
|head invasion (X=0)||53||3(5.7)*|
|0||< X <||500||10||0(0)||65||0(0)|
|500||≤ X <||1000||7||0(0)||58||0(0)|
|1000||≤ X <||1500||11||1(9.1)*||52||6(11.5)|
|1500||≤ X <||2000||7||1(14.3)*||82||10(12.2)|
|2000||≤ X <||2500||10||1(10.0)*||84||13(15.3)|
|2500||≤ X <||3000||4||0(0)||71||8(11.3)|
|3000||≤ X <||3500||9||2(22.2)||72||5(6.9)|
|Lymph node metastasis n (%)||0 ⁄101 (0)||8 ⁄129 (6.2)||8 ⁄230 (3.5)|
|95% CI (%)||0.00–3.60P||2.70–11.90||1.50–6.70|
|*P = 0.02|
|Recurrence n (%)||0 ⁄219 (0)||1 ⁄121 (0.8)||1 ⁄340 (0.3)|
|95% CI (%)||0.00–1.70||0.02–4.50||0.01–1.60|
|**P = 0.72|
|Lymphovascular invasion†, n (%)||35 ⁄240 (15)||55 ⁄144 (38)||90 ⁄384 (23)|
|Lymphatic invasion, n (%)||21 (9)||33 (23)||54 (14)|
|Venous invasion, n (%)||16 (7)||37 (26)||53 (14)|
|Poorly differentiated component, n (%)||26 ⁄240 (11)||26 ⁄144 (18)||52 ⁄384 (14)|
5. The treatment of colorectal carcinoma with submucosal invasion state after endoscopic resection
Many new treatment methods have been developed over the last few decades. The Japanese Society for Cancer of the Colon and Rectum guidelines 2010 for the treatment of colorectal cancer (JSCCR Guidelines 2010 ) have been prepared to show standard treatment strategies for submucosal invasive colorectal cancer (Figure. 6).
6. Detection of desmoplastic reaction in biopsy specimens of colorectal cancer
Early CRC, including submucosal invasive colorectal carcinoma (SICC), is deﬁned as a tumor whose invasion is limited to the mucosa or submucosa. The endoscopic resection (EMR/ESD) have been useful for early CRC. However, endoscopic resection is applicable only to intramucosal carcinoma (Tis stage tumor), and additional surgery is required if the resected specimen reveals submucosal invasion by pathological diagnosis. However, the study of Japanese Society for Cancer of the Colon and Recum have recently demonstrated that the depth of submucosal invasion is closely correlated with the prevalence of lymph node metastasis in patients with SICC (See. Correlations between lymph node metastasis and early colorectal Carcinoma).
Therefore, gastrointestinal endoscopist and surgical pathologist considered that it would be very useful to predict the depth of invasion of SICC before endoscopic resection for case selection. New endoscopic systems are possible to predict submocosal invasion depth without biopsy. However, these developed systems have not been used in everywhere. On the other hand, the stromal change associated with carcinoma invasion has been called desmoplastic reaction (DR), desmoplasia, and cancer-associated fibroblast. Reported incidence of the DR is suggested to be a prognostic marker in CRC patients [16, 17]. Recently, JSCCR studies have been assessed the DR in pretreatment biopsy specimens of SICRC to predict the submucosal depth in retorospective and prospective study.
The DR is characterized by modifications in the composition of stromal cells and extracellular matrix (ECM) components with eosinophilic change [18, 19] (Figure. 8). The main producers of many ECM compounds and represent the major cellular component including DR that often show differentiated phenotype with expression of the smooth muscle actin, platelet derived growth factor receptor- type I collagen [18, 20, 21].
The presence and histological ﬁndings of DR in biopsy specimens were evaluated by pathologists at each respective institute and the criteria for assessment of DR established in consensus meeting among JSCCR members including us. (Table 6).
|1) Existence of carcinoma is required for detection of DR.|
|2) The histological ﬁndings of inﬁltrating carcinoma do not signify the presence of DR.|
|3) DR contains areas of collagen ﬁber accumulation and myoﬁbroblast proliferation, but inﬂammatory inﬁltration does not signify the presence of DR.|
|4) All histological ﬁndings were determined by HE stain alone; detection of DR does notrequire the use of any special stains.|
A retorospective study for detection of desmoplastic reaction in biopsy specimens of early colorectal cancer reported that 359 patients with SICRCs, who had undergone surgical or endoscopic mucosal resection, were analysed . For pedunculated (Ip type) SICRCs was not signiﬁcantly related to submucosal depth. However, for nonpedunculated (non-Ip type) the prevalence of DR in pretreatment biopsy specimens was signiﬁcantly related to submucosal depth. When nonpedunculated(non-Ip type) SICRCs were further divided using a speciﬁc cut off value of 1000 µm for submucosal depth, the positivity ratio of DR in pretreatment biopsy specimens was signiﬁcantly higher in SICRCs with an submucosal depth of 1000 µm than in cases where the submucosal depth was <1000 µm (Table 7). Detection of DR in pretreatment biopsy specimens is useful for the prediction of submucosal depth in nonpedunculated (non-Ip) SICRCs,
|X<1000||3 (37.5)||5 (62.5)||30 (65.2)||16 (34.8)|
|1000 ≤ X < 2000||1 (50.0)||1 (50.0)||25 (56.8)||19 (43.2)|
|2000 ≤ X < 3000||5 (100)||0 (0.0)||22 (27.5)||58 (72.5)|
|3000 ≤ X < 4000||3 (33.3)||6 (66.7)||20 (29.9)||47 (70.1)|
|4000 ≤ X < 5000||0 (0.0)||1 (100)||11 (31.4)||24 (68.6)|
|5000 ≤ X < 6000||1 (100)||0 (0.0)||10 (43.5)||13 (56.5)|
|6000 ≤ X < 7000||2 (100)||0 (0.0)||5 (55.6)||4 (44.4)|
|7000 ≤ X < 8000||0 (0.0)||2 (100)||0 (0.0)||4 (100)|
|8000 ≤ X < 9000||0 (0.0)||0 (0.0)||4 (44.4)||5 (55.6)|
|9000 ≤ X < 10000||0 (0.0)||0 (0.0)||0 (0.0)||4 (100)|
|10000 ≤X||1 (50.0)||1 (50.0)||2 (33.3)||4 (66.7|
After retorospective study , same study group confirmed verification of patients SICRC with 112 nonpedunculated (non-Ip type) cases. Finally, nonpedunculated (non-Ip type) case of the prevalence of DR was signiﬁcantly correlated with submucosal depth. The sensitivity and speciﬁcity of detection of DR for prediction of pSM2 (tumor invasion <1000 µm) in nonpedunculated SICRC were 68.6% and 92.0%, respectively.
Additionally, receiver operating characteristic (ROC), analysis conﬁrmed 950 µm as the best diagnostic cut-off value of submucosal depth for DR detection, and 50 µm, which is the difference between the value of 950 µm as determined by cut off value (COV) and 1000 µm, the deﬁning value of pSM2, is an acceptable measurement error range.
In statistics and diagnostic testing, positive predictive value (PPV) is the proportion of patients with positive test results who are correctly diagnosed, on the other hand, negative predictive value (NPV) is negative test results. Both of PPV and NPV are critical measure of the performance of a diagnostic method. In this studies revealed that PPV:0.93, NPV:0.59 in pedunculated and PPV:0.95, NPV:0.59 in nonpedunculated type. These results provide a basis for assessment of DR as a good indicator of pSM2. (Table 8).
|pSM2, SM invasion ≧1000 µm; pM + pSM1, SM invasion < 1000 µm.
Sensitivity: (37/37+ 17) x 100 = 68.5%.
Speciﬁcity: (24/24+ 3) x 100 = 88.9%.
DR, desmoplastic reaction.
|pSM2, SM invasion ≧1000 µm; pM + pSM1, SM invasion < 1000 µm.
Sensitivity: (35/35+ 16) x100 = 68.6%.
Speciﬁcity: (23/23+ 2) x 100 = 92.0%.
DR, desmoplastic reaction.
In this issue, we have discussed the a critical role of pathological assessment for T1 stage colorectal cancer, several problems related to the pathological diagnosis of early CRC at increased risk of lymph node metastasis and submucosal invasion. A new endoscopic systems which may prove to be reliable for detection of deep submucosal invasive CRC. Moreover, current endoscopic resection (EMR/ESD) have become useful for early CRC, but, these resection is applicable only to intramucosal carcinoma, and additional surgery is required if the resected lesion reveals submucosal invasion by pathological diagnosis, because prevalence rates of lymph node metastasis about 10% of all patients with submucosal invasive colorectal carcinoma.
We believe that curative endoscopic management for early CRC may be need to accurately pathological diagnosis of submucosal depth. Assessment of DR in pretreatment biopsy specimen nonpedunculated (non-Ip type) and submucosal depth with head invasion or stalk invasion in pedunculated (Ip type) for post endoscopic resection (EMR/ESD) specimen may be useful for the clinicopathological diagnosis of colorectal carcinoma with invasion into the submucosal layer.
The authors would like to thank member of Japanese Society for Cancer of the Colon and Recum; Professor Ajioka (Division of Molecular and Functional Pathology, Department of Cellular Function, Graduate School of Medical and Dental Sciences, Niigata University), Dr Ueno (Department of Surgery, National Defense Medical College, Saitama, Professer Ohkura (Department of Pathology, Kyorin University School of Medicine), Professor Kashida (Department of Gastroenterology and Hepatology, Faculty of Medicine, Kinki University), Professor Togashi (Department of Gastroenterology, Fukushima Prefectural Aizu General Hospital), Professor Yao (Department of Human Pathology, Juntendo University School of Medicine) Dr Wada (Department of Pathology, Juntendo Shizuoka Hospital of Juntendo University School of Medicine), Professor Watanabe (Department of Surgical Oncology The University of Tokyo), Dr Ochiai (Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East), Professor Sugai (Diagnostic Pathology, Iwate Medical University, Morioka), Professor Sugihara (Surgical Oncology, Tokyo Medical and Dental University). And we also thank Dr Fujii (Center for Gastrointestinal Endoscopy, Kyoto-Katsura Hospital) for his insightful comments. Moreover, the authors greatly thank Ms C. Sato -Matsuyama, A. Shimizu, M. Katayama, (Department of Surgical and Molecular Pathology, DOKKYO Medical University School of Medicine) for technical assistance and to Ms. S. Kidachi, A. Kikuchi (Department of Surgical and Molecular Pathology, DOKKYO Medical University School of Medicine) for secretarial assistance in preparing the manuscript.
This work was partially supported by the Grant-in-Aid for Scientific Research (C: No 18659101, 23590410) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and DOKKYO Medical University Young Investigator Award (2009, 2011, 2012).
Morson. BC, Whiteway JE, Jones EA, Macrae FA, Williams CB. Histopathology and prognosis of malignant colorectal polyps treated by endoscopic polypectomy. Gut 1984;25(5): 437-444.
Fujimori T, Kawamata H, Kashida H. Precancerous lesions of the colorectum. Journal of gastroenterology 2001;36(9): 587-594.
Kitajima K, Fujimori T, Fujii S, Takeda J, Ohkura Y, Kawamata H, Kumamoto T, Ishiguro S, Kato Y, Shimoda T, Iwashita A, Ajioka Y, Watanabe H, Watanabe T, Muto T, Nagasako K. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. Journal of gastroenterology 2004;39(6): 534-543..
Al Natour RH, Saund MS, Sanchez VM, Whang EE, Sharma AM, Huang Q, Boosalis VA, Gold JS. Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection. Journal of gastrointestinal surgery 2012;16(3): 595-602.
Cooper HS. Surgical pathology of endoscopically removed malignant polyps of the colon and rectum. The American journal of surgical pathology 1983;7(7): 613-623.
Minamoto T, Mai M, Ogino T, Sawaguchi K, Ohta T, Fujimoto T, Takahashi Y. Early invasive colorectal carcinomas metastatic to the lymph node with attention to their nonpolypoid development. The American journal of gastroenterology 1993;88(7): 1035-1039.
Coverlizza S, Risio M, Ferrari A, Fenoglio-Preiser CM, Rossini FP. Colorectal adenomas containing invasive carcinoma: pathologic assessment of lymph node metastatic potential. Cancer 1989;64(9): 1937-1947.
Netzer P, Forster C, Biral R, Ruchti C, Neuweiler J, Stauffer E, Schönegg R, Maurer C, Hüsler J, Halter F, Schmassmann A. Risk factor assessment of endoscopically removed malignant polyps. Gut 1998;43(5): 669-674.
Haggitt RC, Glotzbach RE, Soffer EE, Wruble LD. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy. Gastroenterology 1985;89(2): 328-36.
Pollard CW, Nivatvongs S, Rojanasakul A, Reiman HM, Dozois RR. The fate of patients following polypectomy alone for polyps containing invasive carcinoma. Diseases of the colon and rectum 1992;35(10): 933-937.
Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2005 for the treatment of colorectal cancer. In Japanease, Tokyo, Kanehara: 2005.
Matsuda T, Fukuzawa M, Uraoka T, Nishi M, Yamaguchi Y, Kobayashi N, Ikematsu H, Saito Y, Nakajima T, Fujii T, Murakami Y, Shimoda T, Kushima R, Fujimori T. Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: a retrospective multicenter study. Cancer science 2011;102(9): 1693-1697
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. International journal of clinical oncology 2012;17(1): 1-29.
Prall F. Tumour budding in colorectal carcinoma. Histopathology 2007;50(1): 151-162.
Ueno H, Murphy J, Jass JR, Mochizuki H, Talbot IC. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40(2): 127-132.
Nakada I, Tasaki T, Ubukata H, Goto Y, Watanabe Y, Sato S, Tabuchi T, Tsuchiya A, Soma T. Desmoplastic response in biopsy specimens of early colorectal carcinoma is predictive of deep submucosal invasion. Diseases of the colon and rectum 1998;41(7): 896-900.
Tsujino T, Seshimo I, Yamamoto H, Ngan CY, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clinical cancer research 2007;13(7): 2082-2090.
Ban S, Shimizu M. Muscularis mucosae in desmoplastic stroma formation of early invasive rectal adenocarcinoma. World journal of gastroenterology 2009;15(39): 4976-4979.
Karagiannis GS, Petraki C, Prassas I, Saraon P, Musrap N, Dimitromanolakis A, Diamandis EP. Proteomic signatures of the desmoplastic invasion front reveal collagen type XII as a marker of myofibroblastic differentiation during colorectal cancer metastasis. Oncotarget. 2012;3(3): 267-285.
De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. International journal of cancer 2008;123(10): 2229-2238.
Kimura R, Fujimori T, Ichikawa K, Ajioka Y, Ueno H, Ohkura Y, Kashida H, Togashi K, Yao T, Wada R, Watanabe T, Ochiai A, Sugai T, Sugihara K, Igarashi Y. Desmoplastic reaction in biopsy specimens of early colorectal cancer: A Japanese prospective multicenter study. Pathology international 2012;62(8): 525-531.
Schmid SA, Dietrich A, Schulte S, Gaumann A, Kunz-Schughart LA. Fibroblastic reaction and vascular maturation in human colon cancers. International journal of radiation biology 2009;85(11): 1013-1025.
Hirose M, Fukui H, Igarashi Y, Fujimori Y, Katake Y, Sekikawa A, Ichikawa K, Tomita S, Imura J, Ajioka Y, Ueno H, Hase K, Ohkura Y, Kashida H, Togashi K, Nishigami T, Matsui T, Yao T, Wada R, Matsuda K, Watanabe T, Ochiai A, Sugai T, Sugihara K, Fujimori T. Detection of desmoplastic reaction in biopsy specimens is useful for predicting the depth of invasion of early colorectal cancer: a Japanese collaborative study. Journal of gastroenterology 2010;45(12): 1212-1218.